Springer Nature
Browse
12929_2019_585_MOESM2_ESM.tif (430.89 kB)

MOESM2 of Hypoxia and therapeutic treatment of EV-A71 with an immune modulator TLR7 agonist in a new immunocompetent mouse model

Download (430.89 kB)
figure
posted on 2019-11-12, 05:03 authored by An-Ting Liou, Chun-Che Liao, Shu-Fan Chou, Ya-Shu Chang, Chih-Shin Chang, Chiaho Shih
Additional file 2: Figure S2. Inhibition of IFN signaling enhanced EV-A71 infection and pathogenesis. a When treated with IFNAR neutralizing antibody, a trend of more severe paralysis rate was observed. However, no statistical significance was noted between the experimental group treated with neutralizing antibody and the control group treated with mouse IgG antibody. b IFNG (interferon-gamma) antibody was administered on 1, 2, and 3 dpi. Although a trend of more severe paralysis rate was observed, no statistical significance was noted between the experimental group and the control group.

Funding

Academia Sinica

History

Usage metrics

    Journal of Biomedical Science

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC